MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Boston Scientific to lay off 106 following Lotus Edge heart valve retirement

Boston Scientific to lay off 106 following Lotus Edge heart valve retirement

By

Boston ScientificBoston Scientific (NYSE:BSX) is set to lay off 106 employees in Minnesota following the retirement of its Lotus Edge device, according to reports.

Bring Me the News reported that the company is permanently laying off the 106 workers at its Maple Grove, Minn. location, having notified the state of Minnesota via a WARN letter, as is required by law. The layoffs will begin on Jan. 19, 2021.

The letter stated that, as a result of the voluntary recall and retirement of its Lotus Edge transcatheter aortic valve repair (TAVR) system announced yesterday, the operational unit associated with it will be closed and the employees will be laid off.

“Unfortunately, the decision to stop investing in the Lotus Edge platform means we will immediately stop all associated production and new product development activities, resulting in the elimination of certain roles,” a Boston Scientific spokesperson told MassDevice via email. “At this time, we anticipate that approximately 100 Minnesota-based and field roles will be eliminated, and we are actively seeking to reduce any impacts through redeployments within Boston Scientific. Approximately 40 of those roles are located in Minnesota. The field-based roles are located throughout the country, and report into the interventional cardiology division which is based in Minnesota.”

The spokesperson noted that the company is not communicating a company-wide number at this time because it is actively seeking to reduce job loss through redeployments within the company. When a change impacts an employee, Boston Scientific has resources in place to support those in transition, the spokesperson said.

Marlborough, Mass.-based Boston Scientific said in a news release yesterday that the recall of all unused inventory of its Lotus Edge transcatheter aortic valve repair (TAVR) system is due to complexities related to the product delivery system and solely that — as the valve has achieved positive and clinically effective performance post-implant.

Because of the additional time and investment required to develop and reintroduce an enhanced delivery system, Boston Scientific officials decided to retire the Lotus product platform immediately, ceasing all related commercial, clinical, research & development and manufacturing activities.

In case you missed it

RSS From Medical Design & Outsourcing

  • 3D ‘lung-on-a-chip’ will test COVID-19 drugs
    Researchers in Boston have developed a novel technology to study the effects of COVID-19 and on lung tissue, and to test treatments for it. The “3-D lung-on-a-chip” by Brigham & Women’s Hospital researchers models the distal lung and alveolar structures — the tiny air sacs that take in oxygen as you breathe. They are studying… […]
  • FDA maps return to inspection normalcy
    The FDA has mapped out how it plans to catch up on pandemic-delayed facility inspections — including 2,426 medtech inspections. In a new report called Resiliency Roadmap for FDA Inspectional Oversight, the agency said it will prioritize inspections in terms of urgency and the threat posed by COVID-19 domestically and abroad. The FDA had planned… […]
  • Zimmer Biomet is looking to put sensors in more than just knee implants
    Even as Zimmer Biomet prepares to launch its Persona-IQ smart knee implant later this year, the ortho device giant is looking at additional opportunities to package sensors inside ortho implants. Startup Canary Medical (Vancouver, British Columbia), which created the Canary Health Implantable Reporting Processor (CHIRP) that is going inside the Persona-IQ, has cemented a long-term… […]
  • Protolabs meets on earnings, beats on revenue in Q1
    Protolabs (NYSE: PRLB) today met the Wall Street consensus on its Q1 earnings, surpassing analysts’ expectations when it came to revenue. The Maple Plain, Minn.–based digital manufacturer — which supports medtech and many other industries — reported profits of $3.7 million, or 13¢ per share — about a quarter of the profits that Protolabs saw… […]
  • Allied Motion releases motion control design guide for surgical robots
    Allied Motion Technologies (Amherst, N.Y.) has released a new guide to its custom motion control products for advanced medical robot applications. The guide highlights several motors, drives and control systems, and the uses of each for specific applications. Allied offers co-design and development, has ISO 13485-certified production facilities and a global supply chain . Specific… […]
  • Quasar Medical names new CEO
    Contract manufacturer Quasar Medical announced today that its board of directors has named Alex Wallstein as CEO. Ayal Amitai, CEO since July 2005, is stepping down and transitioning to executive director of the board and senior advisor to the CEO, as well as retaining his shareholdings in Quasar. Wallstein comes with many years of senior… […]
  • Wytech Industries names new president
    Specialty and precision wire manufacturer Wytech Industries (Rahway, N.J.) today announced it has named David Ohmann as president. Ohmann has nearly 25 years of experience in international, orthopedic and advanced surgical medical device segments. Prior to joining Wytech, Ohmann held sales and marketing leadership positions at Heraeus and MicroGroup (a TE Connectivity company). Ohmann has a… […]
  • Spectrum Plastics acquires Laser Light Technologies
    Spectrum Plastics Group has announced the acquisition of substantially all assets of Laser Light Technologies. An ISO 9001- and ISO 13485-certified organization based in Hermann, Mo., Laser Light Technologies provides custom laser processing systems and services using excimer, femtosecond, picosecond and YAG laser technologies. “The addition of the talented team at Laser Light Technologies brings… […]
  • Dymax announces deal with coatings company
    Dymax and nanocoatings manufacturer HZO today announced a strategic partnership. The deal will add 3,000 coatings formulations to HZO’s portfolio, facilitate joint product development, and use Dymax’s global sales channel to extend market reach. Dymax (Torrington, Conn.) manufactures rapid light-cure adhesives, conformal coatings, potting compounds and complementary dispensing and curing equipment used in medtech and… […]
  • Qosina releases 2022 catalog
    Qosina said today it has released the latest edition of its product catalog in both print and digital formats. The 2022 product catalog includes thousands of single-use medical and pharma components depicted in full-scale photos on a one-centimeter grid to help design engineers visualize their next-generation medical device, according to the Ronkonkoma, N,.Y.-based company. Qosina… […]
  • Medline completes $1.5B spending plan
    Medline Industries announced this week that it has completed a three-year, $1.5 billion capital spending campaign. The Northfield, Ill.-based company, which is reportedly up for sale, said it invested the money in new distribution centers, manufacturing capabilities and IT upgrades to improve customers’ e-commerce experience. All told, the initiative added approximately 8,500 new jobs, eight… […]